Barclays now sees two Fed cuts this year, says jumbo Fed cuts ’very unlikely’
In a recent transaction, Fordyce Marshall, President and CEO of Vera Therapeutics, Inc. (NASDAQ:VERA), sold shares totaling approximately $730,535. This sale involved 17,500 shares of Class A Common Stock, with prices ranging from $41.5335 to $42.0334 per share. The stock, which has delivered an impressive 120% return over the past year according to InvestingPro, currently trades at $37.02. The sales were executed under a Rule 10b5-1 trading plan, which was adopted by Marshall in April 2024.
Additionally, Marshall acquired a total of 17,500 shares through stock option exercises at a price of $2.8968 per share. Following these transactions, Marshall's direct ownership stands at 143,603 shares.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.